Amprius Technologies Inc AMPX 深 沪
已收盘 02-06 16:00:00 美东时间
12.24
+1.660
+15.69%
华盛通- 最 高12.28
- 今 开11.275
- 成交量 855.35万股
- 最 低 11.0201
- 昨 收 10.58
- 总市值 15.97亿
- 52周最高 16.03
- 市盈率 静 --
- 换手率 0.01%
- 52周最低 1.70
- 委 比 -45.27%
- 总股本 1.30亿
- 历史最高 26.01
- 量 比 0.68
- 振 幅 11.91%
- 历史最低 0.6132
- 每 手 1
- 风险率 3.94%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多10 Industrials Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. ...
02-05 01:35
What's Going On With Shares Of Amprius Technologies?
Amprius Technologies Inc. shares are surging Tuesday following the announcement of a strategic manufacturing partnership with Nanotech Energy.
02-04 00:35
Amprius Technologies Partners with Nanotech Energy to Boost U.S. Battery Production
Amprius Technologies Partners with Nanotech Energy to Boost U.S. Battery Production Amprius Technologies Inc., a leader in next-generation lithium-ion batteries, has announced a manufacturing partnership with Nanotech Energy, a U.S.-based energy company specializing in advanced lithium-ion batteries
02-03 21:31
A Look at Atkore's Upcoming Earnings Report
Atkore (NYSE:ATKR) is set to give its latest quarterly earnings report on Tuesd...
02-03 01:02
美股大行评级 | Meta 、IBM、拉姆研究、布林克国际等获多家机构上调目标价；微软、特斯拉、ServiceNow、自动数据处理等遭多家下调评级
今日重点评级关注：Piper Sandler：上调Korro Bio评级至"超配"，目标价从11美元升至30美元；Piper Sandler：维持Nurix Therapeutics"超配"评级，目标价从32美元升至35美元
01-30 17:38
Needham Initiates Coverage On Amprius Technologies with Buy Rating, Announces Price Target of $20
Needham analyst Austin Bohlig initiates coverage on Amprius Technologies (NYSE:AMPX) with a Buy rating and announces Price Target of $20.
01-29 18:54
Oppenheimer’s best small and mid-cap ideas for 2026
Oppenheimer Research released a list of its best ideas for small-caps and mid-caps in the new year. Analysts said that, absent the traditional warning signs that have historically preceded market down...
01-07 00:59
美股周涨跌榜 | 奥麦罗制药周涨近64%！关键药物获FDA批准；矿业股HYMC周涨逾52%
奥麦罗制药周涨近64%！关键药物获FDA批准；矿业股HYMC周涨逾52%，此前宣布高品位银钻探结果；德纳维制药周涨近42%，获制药巨头赛诺菲安万特收购>>
2025-12-27 09:57
Amprius Technologies Appoints President Tom Stepien As CEO, Effective January 1, 2026, Succeeding Dr. Kang Sun
Amprius President Tom Stepien appointed Chief Executive Officer by Board of Directors, effective January 1, 2026Dr. Kang Sun to retire at the end of 2025 and will continue serving on the Amprius Board while acting as an
2025-12-22 21:37
Peering Into Amprius Technologies Inc's Recent Short Interest
Amprius Technologies Inc's (NYSE:AMPX) short interest as a percent of float has...
2025-12-19 23:00
